-
Blog BLOG
-
Product Center BRAND DYNAMICS
-
Investor INVESTOR RELATIONS
-
Contact Us CONTACT
-
Supervise SUPERVISION
Joincare Pharmaceutical Group Industry Co., Ltd. Diversity, Equity and Inclusion Policy
Time Posted:2024-08-27 09:42
Time Posted:2024-08-26 12:00
Since the beginning of this year, the innovative drug industry has seen a flurry of favorable policies. From comprehensive support programs to optimized clinical trial review and approval notices, and pilot programs in Beijing and Shanghai, these developments mark a transition in China's innovative drug industry from research and development investment to value realization. However, before these policy benefits are fully realized, a major challenge facing innovative pharmaceutical companies is how to achieve stable operations during this period of industry adjustment. HealthGen has submitted an answer centered on "innovation" and "stability".
Jiankangyuan's anti-influenza drug application for market listing
Time Posted:2024-08-12 17:35
On August 12, the CDE website showed that the marketing application for the influenza drug TG-1000 capsules of Jiankangyuan has been accepted.
2024 Top 100 Pharmaceutical Industry Comprehensive Competitiveness Ranking Released!
Time Posted:2024-08-10 20:00
On August 10th, at the West P Evening Banquet themed "Glory Beyond, Sparkling Stars", the Zhongkang Industry Research Institute released the 2024 Pharmaceutical Industry Comprehensive Competitiveness Index, and based on the index, generated the "2024 Pharmaceutical Industry Comprehensive Competitiveness Top 100 List." 100 benchmark enterprises received industry-wide accolades, composing a hymn of glory.
Applause! Lizhu has won the MSCI ESG Global AAA rating for consecutive years.
Time Posted:2024-08-02 12:40
Recently, MSCI (Morgan Stanley Capital International), a leading international index company, announced the latest annual ESG (Environmental, Social and Governance) rating results for Lizhu. In 2024, Lizhu's MSCI ESG rating has retained the highest global rating of AAA.
Time Posted:2024-07-30 18:05
Driven by its dual-wheel strategy of "innovative drugs + high-end complex preparations", the well-known pharmaceutical company Health Yuan is continuing to lead in the inhalation preparation field. Moreover, since its listing in 2001, Health Yuan has maintained a stable dividend policy, having distributed cash dividends to shareholders 20 times, with a cumulative dividend amount exceeding 3.6 billion yuan.
Time Posted:2024-07-30 14:55
As an active promoter and practitioner of chronic disease public welfare undertakings, Health Yuan continues to promote the "Chronic Disease Public Welfare Supporting Rural Revitalization" action to various needy areas across the country. In May, Health Yuan & Lizhu Group, in collaboration with the Chengdu Xindu Community Development Foundation, Pengzhou Civil Affairs Bureau, Pengzhou's counterpart support team for Heishui County, and Heishui County Health and Health Bureau, implemented the chronic disease public welfare action in Heishui County.
Quick Navigation
+86 755-33268688 | Service Hotline
Official WeChat Official Account
Copyright © 2025 Joincare Pharmaceutical Group Industry Co., Ltd. ALL Rights Reserve.
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
COOKIES
Our website uses cookies and similar technologies to personalize the advertising shown to you and to help you get the best experience on our website. For more information, see our Privacy & Cookie Policy
These cookies are necessary for basic functions such as payment. Standard cookies cannot be turned off and do not store any of your information.
These cookies collect information, such as how many people are using our site or which pages are popular, to help us improve the customer experience. Turning these cookies off will mean we can't collect information to improve your experience.
These cookies enable the website to provide enhanced functionality and personalization. They may be set by us or by third-party providers whose services we have added to our pages. If you do not allow these cookies, some or all of these services may not function properly.
These cookies help us understand what you are interested in so that we can show you relevant advertising on other websites. Turning these cookies off will mean we are unable to show you any personalized advertising.
Sorry,当前栏目暂无内容!
您可以查看其他栏目或返回 首页
Sorry,The current column has no content!
You can view other columns or return Home